» Articles » PMID: 35362531

Emerin Regulation of Nuclear Stiffness is Required for Fast Amoeboid Migration in Confined Environments

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2022 Apr 1
PMID 35362531
Authors
Affiliations
Soon will be listed here.
Abstract

When metastasizing, tumor cells must traverse environments with diverse physicochemical properties. Recently, the cell nucleus has emerged as a major regulator of the transition from mesenchymal to fast amoeboid (leader bleb-based) migration. Here, we demonstrate that increasing nuclear stiffness through elevating lamin A, inhibits fast amoeboid migration in melanoma cells. Importantly, nuclei may respond to force through stiffening. A key factor in this process is the inner nuclear membrane (INM) protein emerin. Accordingly, we determined the role of emerin in regulating fast amoeboid migration. Strikingly, we found that both the up- and downregulation of emerin results in an inhibition of fast amoeboid migration. However, when key Src phosphorylation sites were removed, upregulation of emerin no longer inhibited fast amoeboid migration. Interestingly, as measured by using a Src biosensor, activity of Src was low in cells within a confined environment. Thus, the fast amoeboid migration of melanoma cells depends on the precise calibration of emerin activity.

Citing Articles

At the nucleus of cancer: how the nuclear envelope controls tumor progression.

Paganelli F, Poli A, Truocchio S, Martelli A, Palumbo C, Lattanzi G MedComm (2020). 2025; 6(2):e70073.

PMID: 39866838 PMC: 11758262. DOI: 10.1002/mco2.70073.


Imaging-Based Molecular Interaction Between Src and Lamin A/C Mechanosensitive Proteins in the Nucleus of Laminopathic Cells.

Petrini S, Bagnato G, Piccione M, DOria V, Apollonio V, Cappa M Int J Mol Sci. 2025; 25(24.

PMID: 39769130 PMC: 11678420. DOI: 10.3390/ijms252413365.


A multiparametric screen uncovers FDA-approved small molecules that potentiate the nuclear mechano-dysfunctions in ATR-defective cells.

Cera M, Bastianello G, Purushothaman D, Andronache A, Ascione F, Robusto M Sci Rep. 2024; 14(1):30786.

PMID: 39730498 PMC: 11680690. DOI: 10.1038/s41598-024-80837-w.


Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment.

Popeda M, Kowalski K, Wenta T, Beznoussenko G, Rychlowski M, Mironov A Exp Mol Med. 2024; 56(9):2016-2032.

PMID: 39218980 PMC: 11446916. DOI: 10.1038/s12276-024-01308-w.


Emerin deficiency drives MCF7 cells to an invasive phenotype.

Hansen E, Rolling C, Wang M, Holaska J Sci Rep. 2024; 14(1):19998.

PMID: 39198511 PMC: 11358522. DOI: 10.1038/s41598-024-70752-5.